Shukra Pharmaceuticals has enclosed the Certificate issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 by Purva Sharegistry (India), the Registrar and Share Transfer Agent (RTA) of the Company, confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the second quarter ended September 30, 2023.
The above information is a part of company’s filings submitted to BSE.